A detailed history of Oberweis Asset Management Inc transactions in Ardelyx, Inc. stock. As of the latest transaction made, Oberweis Asset Management Inc holds 579,300 shares of ARDX stock, worth $3.01 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
579,300
Previous 371,800 55.81%
Holding current value
$3.01 Million
Previous $2.76 Million 44.86%
% of portfolio
0.22%
Previous 0.18%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$5.28 - $7.57 $1.1 Million - $1.57 Million
207,500 Added 55.81%
579,300 $3.99 Million
Q2 2024

Aug 14, 2024

BUY
$5.89 - $9.31 $2.19 Million - $3.46 Million
371,800 New
371,800 $2.76 Million

Others Institutions Holding ARDX

About ARDELYX, INC.


  • Ticker ARDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 154,636,000
  • Market Cap $804M
  • Description
  • Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...
More about ARDX
Track This Portfolio

Track Oberweis Asset Management Inc Portfolio

Follow Oberweis Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Oberweis Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oberweis Asset Management Inc with notifications on news.